5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with ascorbic acid in 1 studies
| Studies (5-hydroxy-2-n,n-dipropylaminotetralin) | Trials (5-hydroxy-2-n,n-dipropylaminotetralin) | Recent Studies (post-2010) (5-hydroxy-2-n,n-dipropylaminotetralin) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | 5-hydroxy-2-n,n-dipropylaminotetralin (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonio, T; Dutta, AK; Ghosh, B; Kharkar, P; Reith, ME; Zhen, J | 1 |
1 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and ascorbic acid
| Article | Year |
|---|---|
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Free Radical Scavengers; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Locomotion; Mice; Parkinson Disease; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Structure-Activity Relationship; Thiazoles | 2010 |